NASDAQ: OBSVObseva Sa Stock
$0.31+0.02 (+6.9%)
Updated Aug 9, 2022
OBSV Price
$0.31
Fair Value Price
$0.99
Market Cap
$24.39M
52 Week Low
$0.22
52 Week High
$3.35
P/E
-0.48x
P/B
0.87x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$50.17M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
2.19
Operating Cash Flow
-$64M
Beta
0.89
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OBSV Overview
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OBSV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OBSV ($0.31) is undervalued by 69.14% relative to our estimate of its Fair Value price of $0.99 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
OBSV ($0.31) is significantly undervalued by 69.14% relative to our estimate of its Fair Value price of $0.99 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
OBSV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OBSV due diligence checks available for Premium users.
OBSV News
Valuation
OBSV fair value
Fair Value of OBSV stock based on Discounted Cash Flow (DCF)
Price
$0.31
Fair Value
$0.99
Undervalued by
68.64%
OBSV ($0.31) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OBSV ($0.31) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OBSV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
OBSV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.48x
Industry
-5.67x
Market
32.55x
OBSV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.87x
Industry
4.77x
OBSV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OBSV's financial health
Profit margin
Revenue
$0.0
Net Income
-$11.8M
Profit Margin
0%
OBSV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$89.1M
Liabilities
$61.2M
Debt to equity
2.19
OBSV's short-term assets ($64.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OBSV's short-term assets ($64.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OBSV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
OBSV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$15.3M
Investing
$5.7M
Financing
$12.2M
OBSV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
OBSV vs Biotech Stocks
Obseva Sa Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.